Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors

被引：0
|
作者：
Dubay, Derek [1 ]
Lilly, Leslie [1 ]
Smith, Robert [1 ]
Levy, Gory A. [1 ]
Therapondos, George [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, MultiOrgan Transplant Program, Toronto, ON M4X 1K9, Canada
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：495A / 495A
页数：1
相关论文
共 50 条
  • [31] Linear Growth in Pediatric Renal Transplant Recipients Is Similar with Sirolimus vs. Calcineurin Inhibitors.
    Warshaw, Barry L.
    Hymes, Leonard C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 341 - 342
  • [32] Combination of everolimus with low-dose calcineurin-inhibitors in lung transplant recipients with chronic renal insufficiency
    Hoda, M. A. R.
    Jaksch, P.
    Zweytick, B.
    Taghavi, S.
    Lang, G.
    Aigner, C.
    Gaugg, M.
    Keplinger, M.
    Klepetko, W.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S76 - S76
  • [33] Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: Results of a controlled pilot study
    Shitrit, D
    Rahamimov, R
    Gidon, S
    Bakal, I
    Bargil-Shitrit, A
    Milton, S
    Kramer, MR
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (04) : 1471 - 1475
  • [34] Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details...
    McKenna, G. J.
    Trotter, J. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 521 - 522
  • [35] Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation
    Campbell, Mical S.
    Rai, Jitha
    Kozin, Elliott
    Bloom, Roy D.
    Markmann, James F.
    Olthoff, Kim M.
    Shaked, Abraham
    Reddy, K. Rajender
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (03) : 377 - 384
  • [36] COMPARISON OF MTORIS AND CALCINEURIN INHIBITORS IN LOW-IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS
    Yilmaz, Vural Taner
    Kocak, Huseyin
    Suleymanlar, Gultekin
    Cetinkaya, Ramazan
    Kisaoglu, Abdullah
    Aydinli, Bulent
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 254 - 254
  • [37] Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients
    Pescovitz, MD
    Govani, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S16 - S21
  • [38] Defining factors that predict improvement in calcineurin related renal dysfunction in liver transplant patients switched to sirolimus
    Seetharam, Anil B.
    Korenblat, Kevin
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A733 - A733
  • [39] Use of basiliximab with delayed calcineurin inhibitors introduction in living donor liver transplant recipients with renal dysfunction: Lessons we learned
    Mandwar, Milind
    Chaudhary, Abhideep
    Kumar, Niteen
    [J]. TRANSPLANTATION, 2024, 108 (09) : 287 - 287
  • [40] AUC guided dosing of calcineurin inhibitors in renal transplant recipients
    Harpe, M.
    Bouts, A.
    Bunker-Wiersma, H.
    Van Kan, H.
    Davin, J.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1680 - 1680
12345